Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3540)
All Articles published online
|
Dec 15, 2004 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Eisold S, Linnebacher M, Ryschich E, Antolovic D, Hinz U, Klar E, Schmidt J. The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines. World J Gastroenterol 2004; 10(24): 3583-3589 [PMID: 15534911 DOI: 10.3748/wjg.v10.i24.3583] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i24/3583.htm |
| Number | Citing Articles |
| 1 |
Valérie Fauquette, Sébastien Aubert, Sophie Groux-Degroote, Brigitte Hemon, Nicole Porchet, Isabelle Van Seuningen, Pascal Pigny. Transcription factor AP-2α represses both the mucin MUC4 expression and pancreatic cancer cell proliferation. Carcinogenesis 2007; 28(11): 2305 doi: 10.1093/carcin/bgm158
|
| 2 |
Geng Tian, Jiliang Liu, Jie Sui Ruming Zhou, Weihong Chen. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial. Anti-Cancer Drugs 2009; 20(5): 389 doi: 10.1097/CAD.0b013e32832a2df9
|
| 3 |
Y. Touchefeu, K. J. Harrington, J. P. Galmiche, G. Vassaux. Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Alimentary Pharmacology & Therapeutics 2010; 32(8): 953 doi: 10.1111/j.1365-2036.2010.04424.x
|
| 4 |
Mitchell C. Coleman, Carla R. Asbury, David Daniels, Juan Du, Nukhet Aykin-Burns, Brian J. Smith, Ling Li, Douglas R. Spitz, Joseph J. Cullen. 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radical Biology and Medicine 2008; 44(3): 322 doi: 10.1016/j.freeradbiomed.2007.08.032
|
| 5 |
YANPING CUN, QINHONG ZHANG, CHENGJIE XIONG, MENGXIA LI, NAN DAI, SHIHENG ZHANG, DONG WANG. Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo. Oncology Reports 2013; 29(6): 2197 doi: 10.3892/or.2013.2384
|
| 6 |
Achim Temme, Jose A. Rodriguez, Sandy Hendruschk, Serap Günes, Bernd Weigle, Knut Schäkel, Marc Schmitz, Michael Bachmann, Gabriele Schackert, E. Peter Rieber. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Letters 2007; 250(2): 177 doi: 10.1016/j.canlet.2006.09.020
|
| 7 |
Yan Yan, Yulan Qing, John J. Pink, Stanton L. Gerson. Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdU. Molecular Cancer Research 2018; 16(2): 212 doi: 10.1158/1541-7786.MCR-17-0215
|
| 8 |
Q Li, K Kawamura, M Yamanaka, S Okamoto, S Yang, S Yamauchi, T Fukamachi, H Kobayashi, Y Tada, Y Takiguchi, K Tatsumi, H Shimada, K Hiroshima, M Tagawa. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed. Cancer Gene Therapy 2012; 19(3): 218 doi: 10.1038/cgt.2011.86
|
| 9 |
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Marco Falasca, Ramiro M. Murata, Pedro L. Rosalen, Paolo Lombardi, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Linda S. Steelman, James A. McCubrey. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in Biological Regulation 2018; 69: 16 doi: 10.1016/j.jbior.2018.06.002
|
| 10 |
Silvia Alonso-de Castro, Alessio Terenzi, Sonja Hager, Bernhard Englinger, Adriana Faraone, Javier Calvo Martínez, Mathea Sophia Galanski, Bernhard K. Keppler, Walter Berger, Luca Salassa. Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-35655-2
|
| 11 |
Mojtaba Saffari, Orkideh Saydi Dinehkabodi, Seyed Hamid Ghaffari, Mohammad H. Modarressi, Fatemeh Mansouri, Mansour Heidari. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells. Cancer Letters 2009; 273(2): 316 doi: 10.1016/j.canlet.2008.08.020
|
| 12 |
Ibtehal Mohammed, Ali Haider Alhammer, Inam Sameh Arif. The p53 reactivator PRIMA-1MET synergises with 5-fluorouracil to induce apoptosis in pancreatic cancer cells. Investigational New Drugs 2023; 41(4): 587 doi: 10.1007/s10637-023-01380-5
|
| 13 |
Nathan P. Gomes, Joaquín M. Espinosa. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle 2010; 9(17): 3428 doi: 10.4161/cc.9.17.12998
|
| 14 |
Margret Bessadottir, Mar Egilsson, Eydis Einarsdottir, Iris H. Magnusdottir, Margret H. Ogmundsdottir, Sesselja Omarsdottir, Helga M. Ogmundsdottir, Gabriele Multhoff. Proton-Shuttling Lichen Compound Usnic Acid Affects Mitochondrial and Lysosomal Function in Cancer Cells. PLoS ONE 2012; 7(12): e51296 doi: 10.1371/journal.pone.0051296
|
| 15 |
Ivana Grivicich, Andréa Regner, Caroline Zanoni, Larissa Procópio Correa, Geraldo Pereira Jotz, João Antônio Pêgas Henriques, Gilberto Schwartsmann, Adriana Brondani da Rocha. Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines. International Journal of Colorectal Disease 2007; 22(10): 1201 doi: 10.1007/s00384-007-0307-x
|
| 16 |
Xiaodong Qi, Zhikun Chang, Jin Song, Gui Gao, Zheng Shen. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin. Anti-Cancer Drugs 2011; 22(6): 556 doi: 10.1097/CAD.0b013e328345b4e7
|
| 17 |
Janet A. Houghton. Apoptosis, Senescence, and Cancer. Cancer Drug Discovery and Development 2007; : 361 doi: 10.1007/978-1-59745-221-2_19
|
| 18 |
Zhiguo Rao, Jianfei Gao, Bicheng Zhang, Bo Yang, Jiren Zhang. Cisplatin sensitivity and mechanisms of anti-HPV16 E6-ribozyme on cervical carcinoma CaSKi cell line. The Chinese-German Journal of Clinical Oncology 2012; 11(4): 237 doi: 10.1007/s10330-011-0949-6
|